Početna › Atopijski dermatitis (ekcem) › Florida
Kliničke studije za Atopijski dermatitis (ekcem) u državi Florida
18 studija za Atopijski dermatitis (ekcem) traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
- Miami9 studija
- Tampa7 studija
- St. Petersburg5 studija
- Miami Gardens4 studija
- Coral Springs4 studija
- Kendall3 studija
- Boca Raton3 studija
- Hollywood3 studija
- Jacksonville3 studija
Službeni tekst studije (engleski)
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
- Clinical Site 110, Miami
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 65 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07453602This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- St. Jude Clinical Research- Site Number : 8400049, Doral
- Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach
U tijeku regrutacijaOpažajna studija
Od 12 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 28. ruj 2026. · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Fort Lauderdale
- Enveda Investigative Site, Miami
- Enveda Investigative Site, Miramar
U tijeku regrutacijaFaza 2
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07298395A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
U tijeku regrutacijaFaza 2
Od 18 do 64 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07216027A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Coral Gables
- Investigational Site, Jacksonville
- Investigational Site, Margate
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Olympian Clinical Research, Tampa
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 4. ruj 2026. · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- i još 4
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 28. kol 2026. · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 12. kol 2026. · NCT07037901A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Boca Raton
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07643766A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables
U tijeku regrutacijaFaza 3
Od 2 do 11 godina · Oba spola · Ažurirano 6. kol 2026. · NCT06461897FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Miami Dermatology and Laser Research, Miami
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 22. srp 2026. · NCT06564389A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Jacksonville
- Leo Pharma Investigational site, Miami
- Leo Pharma Investigational site, Tampa
U tijeku regrutacijaFaza 3
6 Months – 11 Years · Oba spola · Ažurirano 7. srp 2026. · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Skin Care Research Boca Raton /ID# 263733, Boca Raton
- TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
- Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
- i još 13
U tijeku regrutacijaFaza 3
Od 18 do 63 godina · Oba spola · Ažurirano 6. srp 2026. · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Revival Research, Doral
- Floridian Research Institute Llc, Miami
- Global Health Research Center, Inc., Miami Lakes
- i još 4
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 4. svi 2026. · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8597, Boca Raton
- Galderma Investigational Site 7087, Coral Gables
- Galderma Investigational Site 7063, Cutler Bay
- i još 7
U tijeku regrutacijaOpažajna studija
Od 12 godina i više · Oba spola · Ažurirano 13. ožu 2026. · NCT06988605Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.